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Determination of anti-inflammatory activities of standardised preparations of
plant- and mushroom-based foods
Abstract
Purpose: Chronic inflammatory processes contribute to the pathogenesis of many age-related diseases.
In search of anti-inflammatory foods, we have systematically screened a variety of common dietary plants
and mushrooms for their anti-inflammatory activity.
Methods: A selection of 115 samples was prepared by a generic food-compatible processing method
involving heating. These products were tested for their anti-inflammatory activity in murine N11 microglia
and RAW 264.7 macrophages, using nitric oxide (NO) and tumour necrosis factor-α (TNF-α) as proinflammatory readouts.
Results: Ten food samples including lime zest, English breakfast tea, honey-brown mushroom, button
mushroom, oyster mushroom, cinnamon and cloves inhibited NO production in N11 microglia, with IC50
values below 0.5 mg/ml. The most active samples were onion, oregano and red sweet potato, exhibiting
IC50 values below 0.1 mg/ml. When these ten food preparations were retested in RAW 264.7
macrophages, they all inhibited NO production similar to the results obtained in N11 microglia. In addition,
English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom preparations
suppressed TNF-α production, exhibiting IC50 values below 0.5 mg/ml in RAW 264.7 macrophages.
Conclusion: In summary, anti-inflammatory activity in these food samples survived ‘cooking’. Provided
that individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these
foods may be useful in limiting inflammation in a variety of age-related inflammatory diseases.
Furthermore, these foods could be a source for the discovery of novel anti-inflammatory drugs.
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ABSTRACT

Purpose Chronic inflammatory processes contribute to the pathogenesis of many age-related diseases. In search
of anti-inflammatory foods, we have systematically screened a variety of common dietary plants and
mushrooms for their anti-inflammatory activity.
Methods A selection of 115 samples was prepared by a generic food-compatible processing method involving
heating. These products were tested for their anti-inflammatory activity in murine N11 microglia and RAW
264.7 macrophages, using nitric oxide (NO) and tumour necrosis factor – α (TNF-α) as pro-inflammatory
readouts.
Results Ten food samples including lime zest, English breakfast tea, honey brown mushroom, button mushroom,
oyster mushroom, cinnamon and cloves inhibited NO production in N-11 microglia with IC50 values below 0.5
mg/ml. The most active samples were onion, oregano and red sweet potato, exhibiting IC50 values below 0.1
mg/ml. When these ten food preparations were re-tested in RAW 264.7 macrophages, they are all inhibited NO
production similar to the results obtained in N-11 microglia. In addition, English breakfast tea leaves, oyster
mushroom, onion, cinnamon and button mushroom preparations suppressed TNF-α production, exhibiting with
IC50 values below 0.5 mg/ml in RAW 264.7 macrophages.
Conclusion In summary, anti-inflammatory activity in these food samples survived ‘cooking’. Provided that
individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these foods may
be useful in limiting inflammation in a variety of age-related inflammatory diseases. Furthermore, these foods
could be a source for the discovery of novel anti-inflammatory drugs.

Keywords: food, inflammation, cinnamon, oregano, oyster mushroom
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1.

INTRODUCTION

The increase in both the absolute number as well as relative proportion of the elderly is arguably one of the most
important developments facing human society in the next decades [1]. Age is the leading risk factor for many
devastating diseases such as acute and chronic neurodegenerative diseases, degenerative musculoskeletal
diseases, cardiovascular diseases, diabetes, asthma, rheumatoid arthritis and inflammatory bowel disease.
Increasing evidence suggests that systemic low grade inflammation is a contributing factor in these age-related
diseases [2-6]. To date, pharmacotherapy of inflammatory conditions is based on the use of non-steroidal antiinflammatory drugs (NSAIDs). However, NSAIDs can cause serious gastrointestinal toxicity such as gastric
bleeding and the formation of stomach ulcers [7, 8]. Even more ominously, some NSAIDs, particularly COX-2
inhibitors, have been linked to increased blood pressure, greatly increased risk of congestive heart failure,
occurrence of thrombosis and myocardial infarction [9-11]. Together, these findings provide the motivation for
the development of anti-inflammatory treatments with fewer adverse effects.
Herbal medicines derived from plants rich in the secondary metabolite salicylic acid such as the bark of the
willow tree (Salix alba) have been used for the treatment of diseases with a prominent inflammatory component
for thousands of years. Many other medicinal plants are known to have anti-inflammatory activity but neither
the underlying mechanisms nor their potential for the development of new drugs have been fully explored.
Several mechanisms are proposed to explain their anti-inflammatory action, including inhibition of
cyclooxygenases and lipoxygenases or modulation of pro-inflammatory gene expression such as inducible nitric
oxide synthase, and several pivotal cytokines including TNF-α [12, 13].
However, very few studies have attempted a systematic comparison of a large number of commercially
available plant and mushroom foods in search of those with the highest degree of anti-inflammatory activities.
To close this knowledge gap, we have screened 115 dietary plants and mushrooms for in vitro anti-inflammatory
activities using a generic food-compatible sample processing method involving heating in water, or in the
presence of glucose.
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2.

MATERIALS AND METHODS

2.1. Materials
Plant and mushroom samples in the screening library were obtained from retail suppliers in Melbourne,
Australia. DMSO, 95% ethanol, bovine serum albumin, lipopolysaccharide (LPS) (E.coli serotype 0127:B8),
EDTA, N-(1-1-napthyl) ethylenediaminedihydrochloride, penicillin G sodium benzyl, resazurin sodium,
streptomycin, sulfanilamide, tetra methyl benzidine (TMB), trypan blue were purchased from Sigma-Aldrich,
(Castle Hill, NWS, Australia). Antibiotics, Dulbecco’s modified Eagle’s medium (DMEM), foetal bovine serum
(FBS) and glutamine were purchased from Invitrogen (Mulgrave, Vic, Australia). Murine IFN-γ and TNF-α
ELISA kits were purchased from Peprotech (Rocky Hill, NJ, USA).

2.2 Methods
2.2.1 Preparation of the food and plant library samples
Plant and mushroom library samples were prepared by methods usually employed with food preparation,
involving heating (i.e. ‘cooking’), mechanical dispersion and treatments intended to solubilise both hydrophobic
and hydrophilic solutes. Samples were prepared by blending in a food processor with water (1:2 ratio w/v)
before heating in a microwave for 10 min. under control conditions or including 1% glucose, to enhance
Maillard reaction products. After cooling to room temperature, ascorbic acid (0.1% of initial solids) and ethanol
(1% of initial solids) were added for microbial stabilisation. Samples were ultrasonicated using a 400 W probe
at 100% power for 2 min. (Hielscher 400UPS) before freeze drying.

2.2.2 Maintenance of N11 microglia and RAW 264.7 macrophages
Cells were cultured in 175 cm2 flasks in DMEM containing 5% FBS, supplemented with glutamine (2 mM),
penicillin (200 U/ml), streptomycin (200 μg/ml) and fungizone (2.6 μg/ml). The cell lines were maintained in
5% CO2 at 37°C.
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2.2.3 Pro-inflammatory activation of cells
Cells were seeded at a density of 75,000 /well into each well of a 96-well plate. After 24h, a combination of 25
μg/ml LPS and 10 U/ml IFN-γ diluted in DMEM was used for activation. The food samples were dissolved in
DMEM and insoluble solids were removed by centrifugation at 16,900 x g for 2 min. Samples were added to the
cells an hour prior to addition of the inflammatory activation mix at a maximal concentration of 2.5 mg/ml, from
which 6 doses were made by serial 1:2 dilutions. Cells were incubated for 24 h at 37oC with the inflammatory
activation mix before NO and TNF-α levels were measured.

2.2.4 Measurement of nitrite levels by the Griess assay
NO release was measured through the quantification of nitrite by the Griess assay. The Griess reagent was made
up of equal volumes of 1% sulfanilamide and 0.1% napthyethylene-diamine in 5% HCl. From each well, 80 µl
of cell culture medium was transferred to a fresh 96-well plate and mixed with 80 µl of Griess reagent and after
30 minutes at room temperature absorbance was measured at 540 nm in a POLARstar Omega microplate reader
(BMG Labtech, Mornington, Australia) and expressed as a percentage of that in control cells.

2.2.5 Measurement of TNF-α levels by enzyme linked immunosorbent assay (ELISA)
Determination of TNF-α was performed by ELISA, according to the manufacturer’s instructions (Peprotech)
with minor modifications. Briefly, the capture antibody was diluted to 0.5 μg/ml in phosphate buffered saline
(PBS; 1.9 mM NaH2PO4, 8.1mM Na2HPO4, 154 mM NaCl pH 7.4) and 100 μl of diluted capture antibody was
added to each well of a 96-well plate, sealed with parafilm and incubated overnight at room temperature. The
plate was washed 4 times with washing buffer (0.05% Tween-20 in PBS); 250 μl of blocking buffer (1% BSA in
PBS) was added to each well, the plate was covered and incubated for 1 hour at room temperature. The plate
was again washed 4 times in washing buffer. TNF-α standard was serially diluted from 0 to 10,000 pg/ml in
diluent (0.05% Tween-20, 0.1% BSA in PBS). 50μl of cell supernatant or TNF-α standard in duplicate was
added to each well, the plate was covered and incubated for 2.5 hours at room temperature. Each well was
washed 4 times with washing buffer. Detection antibody was diluted to 0.125 μg/ml in diluent (supplied by the
manufacturer) and 100 μl of diluted detection antibody was added to each well. The plate was covered and
incubated for 2.5 hours before being washed 4 times with washing buffer. Avidin Peroxidase conjugate was
diluted to a ratio of 1:4000 in diluent and 100μl of diluted Avidin Peroxidase conjugate solution was added to
each well, the plate was covered and incubated for 30 minutes before being washed 4 times with washing buffer.
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100μl of 3,3',5,5'-tetramethybenzidine (TMB) Liquid Substrate Solution (0.5 mg TMB dissolved in 1 ml
DMSO, supplemented with 9ml phosphate-citrate buffer and 1µl 30% H2O2) was added to each well.
Absorbance was measured at 655 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington,
Australia), taking readings every 5 min. After 25 min, the reaction was stopped using 0.5M sulphuric acid, and
then the absorbance was measured at a wavelength of 455nm.

2.2.6 Determination of cell viability
The Alamar Blue assay is a colorimetric assay involving the cellular reduction of resazurin to resorufin.
Resazurin was dissolved in PBS to give a concentration of 0.001% (w/v), sterile filtered (0.22 μm), protected
from light with aluminium foil and stored at 4°C for up to six months. To determine cell viability, incubation
media was aspirated from wells and replaced with 100 μl of resazurin solution and incubated at 37°C for 1 h.
After incubation for 1 h, fluorescence of formed resorufin was measured with excitation at 530 nm and emission
at 590 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, Australia) and expressed as a
percentage of that in control cells, after background fluorescence was subtracted.

2.2.7 Data calculation and statistics
Data calculations were performed using MS-Excel 2010 software. IC50 values were obtained by using the
sigmoidal dose-response function in GraphPad Prism. IC50 values from three experiments were averaged (all
performed in triplicate). The results were expressed as mean ± standard deviation. Differences between the same
sample heated in water or glucose were analysed by t-tests using GraphPad Prism.
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3.

RESULTS

3.1 Primary screen of 115 food and mushroom samples using nitric oxide as pro-inflammatory readout

115 commercially available dietary plants and mushrooms were selected (Table 1). Samples were prepared
using a generic food-compatible sample processing method involving heating in water or in the presence of 1%
glucose (to allow modification by the Maillard reaction for form Maillard reaction products, MRPs).

These 115 samples (including 115 identical samples heated with glucose) were then tested for their ability to
down-regulate LPS + IFN-γ induced NO production in N11 microglia (Table 1). Ten foods demonstrated
significant anti-inflammatory activity with IC50 values below 0.5 mg/ml (Table 2). Seven of these food
preparations, including lime zest, English breakfast tea, honey brown mushroom, button mushroom, oyster
mushroom, cinnamon and cloves demonstrated potent anti-inflammatory activity with IC50 values between 0.1
and 0.5 mg/ml (Table 2). However, the most active food samples were onion, followed by oregano and red
sweet potato exhibiting IC50 values below 0.1 mg/ml (Table 3). Furthermore, the MRP modified samples
showed IC50 values in the same order of magnitude as the unmodified samples and, despite significant
differences in some samples between the unmodified and MRP modified samples, no general increase in antiinflammatory activity by the inclusion of glucose in the heating mixture could be detected. All of the active
preparations were non-toxic at the IC50 values (cell viability > 75 %), suggesting that the reduction in NO
production was not simply caused by a decrease in cell number or cell viability.

Table 1: List of food and mushroom samples tested for their anti-inflammatory activity
Category

Foods

Botanical name

Plant part used

Plant family or class of
organism

HERBS

Continental parsley

Petroselinium crispum

dried aerial parts

Apiaceae/Umbelliferae

Tarragon

Artemisia dracunculus

dried leaf

Asteraceae/Compositae

Oregano

Origanum vulgare

dried leaf

Lamiaceae/Labiatae

Rosemary

Rosmarinus officinalis

dried leaf

Lamiaceae/Labiatae

Sage

Salvia officinalis

dried leaf

Lamiaceae/Labiatae

Thyme

Thymus vulgaris

Dried leaf

Lamiaceae/Labiatae

SPICES

Fennel

Foeniculum vulgare

seeds

Apiaceae/Umbelliferae

CONDIMENTS

Coriander

Coriandrum sativum

seeds

Apiaceae/Umbelliferae

Yellow mustard

Brassica hirta

seeds

Cruciferae
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VEGETABLES

Bay leaves

Laurus nobilis

leaves

Lauraceae

Cinnamon

Cinnamomum zeylanicum

bark

Lauraceae

Garlic

Allium sativum

bulb

Lilliaceae

Brown linseed

Linum Usitatissimum

seeds

Linaceae

Cloves

Syzygium aromaticum

flower buds

Myrtaceae

Cardamom

Elattaria cardamomum

fruit

Zingiberaceae

Ginger

Zingiber officinale

rhizome

Zingiberaceae

Turmeric

Curcuma longa

rhizome

Zingiberaceae

Spinach

Spinacia oleracea

aerial parts

Amaranthaceae

Silver beet

Beta vulgaris

tuber

Amaranthaceae

Rainbow silver beet

Beta vulgaris

tuber

Amaranthaceae

Beet root

Beta vulgaris

tuber

Amaranthaceae

Carrot

Daucus carota

tuber

Apiaceae/Umbelliferae

Coriander

Coriandrum sativum

leaves

Apiaceae/Umbelliferae

Black carrot

Daucus carota

tuber

Apiaceae/Umbelliferae

Asparagus

Asparagus officinalis

Asparagaceae

Radiccio

Cichorium intybus

Asteraceae/Compositae

Red coral lettuce

Lactuca sativa

aerial parts

Asteraceae/Compositae

Bok Choi

Brassica chinensis
var.parachinensis

fresh herb

Cruciferae

Brussel srouts

Brassica oleracea gemmifera?

fresh herb

Cruciferae

Chinese Broccoli

Brassical oleracea

fresh herb

Cruciferae

Chinese cabbage

Brassica rapa

fresh herb

Cruciferae

Choi sum

Brassica chinenssis

fresh herb

Cruciferae

Red cabbage

Brassica oleracea var.capitata
rubra

aerial parts

Cruciferae

Savoy cabbage

Brassica oleracea var savoy

Cruciferae

Water cress

Nasturtium officinale

Cruciferae

Red Sweet Potato

Ipomoea batatus

tuber

Convolvulaceae

Choko flesh

Sechium edule

fruit flesh

Cucurbitaceae

Pumpkin

Cucurbita maxima

fruit

Cucurbitaceae

Squash

Cucurbita moschata

fruit

Cucurbitaceae

Choko skin

Sechium edule

skin

Cucurbitaceae

Basil green

Ocimum basilicum

fresh herb

Lamiaceae/Labiatae
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Basil purple

Ocimum basilicum

fresh herb

Lamiaceae/Labiatae

Basil Thai

Ocimum basilicum var.
thrysiflora

fresh herb

Lamiaceae/Labiatae

Green peas

Pisum sativum

seeds

Leguminosae

Chives

Allium schoenoprasum

bulb

Lilliaceae

Leek

Allium porrum

herb

Lilliaceae

Onion

Allium cepa

buld

Lilliaceae

Shallot

Allium cepa var. aggregatum

bulb

Lilliaceae

Spring onion

Allium fistulosum

bulb

Lilliaceae

Red onion

Allium cepa

bulb

Lilliaceae

Corn

Zea mays

seeds

Poaceae

Lemon grass

Cimbopogon citratus

aerial parts

Poaceae

Rhubarb

Rheum palmatum

White potato

Solanum tuberosum

tuber

Solanaceae

MARINE
ALGEA

Spirulina

Arthrospira platensis

Whole organism

Cyanobacteria

FRUITS

Kiwi Gold

Actinidia chinensis

Actinidiaceae

Kiwi green

Actinidia chinensis

Actinidiaceae

Cucumber

Cucumis sativus

Cucurbitaceae

Zucchini white

Cucurbita peop

Cucurbitaceae

Blueberries

Vaccinium corymbosum

Ericaceae

Avocado

Persea americana

Lauraceae

Coconut

Cocos nucifera

Palmae

Quince

Pyrus cydonia

Rosaceae

Raspberries

Rubus idaeus

Rosaceae

Strawberries

Fragaria X ananassa

Rosaceae

Apples Red delicious

Malus domestica

Rosaceae

Ruby grapefruit

Citrus paradisi

Rutaceae

Lime

Citrus aurantifolia

Rutaceae

Mandarine (imperial)

Citrus reticulata

Rutaceae

Lemon flesh

Citrus limon

Rutaceae

Lime zest

Citrus aurantifolia

Rutaceae

Oranges Navel

Citrus sinensis

Rutaceae

Green beans

Polygonaceae
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MUSHROOMS

BEVERAGES

Oranges Valencia

Citrus sinensis

Rutaceae

Orange zest

Citrus sinensis

Rutaceae

Lemon zest

Citrus limon

Rutaceae

Citrus yellow flesh

Citrus limon

Rutaceae

Citrus red skin

"

"

Citrus red flesh

"

"

Citrus yellow skin

"

"

Citrus green

"

"

Tomato

Lycoperisicon esculentum

Solanaceae

Grapes M48-42

Vitis vinifera

Vitaceae

Grapes Chambourcin

"

"

Grapes Cabernet
Sauvignon

"

"

Grapes M12-41

"

"

Grapes Sanmuscat

"

"

Grapes Concord

"

"

Grapes CR101-13

"

"

Grapes CR101-10

"

"

Maitake

Grifola frondosa

fruit body

Polyporaceae

Jew's ear

Auricularia auricula-judae

fruit body

Auriculariaceae

Oyster

Pleurotus ostreatus

fruit body

Pleurotaceae

Honey brown

Agaricus bisporus

fruit body

Agaricaceae

Button

Agaricus bisporus

fruit body

Agaricaceae

Enoki

Flammulina veluptipes

fruit body

Physalacriaceae

Shiitake

Lentinus edodes

fruit body

Tricholomataceae

Coffe beans dark
columbia

Coffea arabica

Rubiaceae

Coffee beans mocha

Coffea arabica

Rubiaceae

Cocoa beans

Theobroma cocoa

Malvaceae

Tea leaves English
breakfast

Camellia sinensis

Theaceae

Sencha tea leaves
Japanese

Camellia sinensis

Theaceae
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Table 2: Food samples with anti-inflammatory activity (IC50: 0.1 – 0.5 mg/ml)
Food Sample

Heated in

IC50 for inhibition of NO

Cell viability at IC50 for NO

production (mg/ml)

(%)

Oyster mushroom

water

0.47 ± 0.28

96 ± 6

Oyster mushroom

glucose

0.27 ± 0.10

98 ± 8

Lime zest

water

0.36 ± 0.06

108 ± 4

Lime zest

glucose

0.13 ± 0.04

93 ± 10

Honey brown mushroom

water

0.16 ± 0.13

106 ± 12

Honey brown mushroom

glucose

0.11 ± 0.04

104 ± 14

Button mushroom

water

0.14 ± 0.01

105 ± 15

Button mushroom

glucose

0.35 ± 0.01

124 ± 2

English Breakfast Tea leaves

water

0.24 ± 0.13

94 ± 3

English Breakfast tea leaves

glucose

0.30 ± 0.21

92 ± 2

Cinnamon

water

0.21 ± 0.10

88 ± 12

Cinnamon

glucose

0.29 ± 0.14

89 ± 14

Cloves

water

0.28 ± 0.06

83 ± 5

Cloves

glucose

0.15 ± 0.01

95 ± 9

Table 3: Food samples with anti-inflammatory activity (IC50< 0.1mg/ml)
Food sample

Heated in

IC50 for inhibition of NO

Cell viability at IC50 for NO

production (mg/ml)

(%)

Onion

water

0.087 ± 0.030

99 ± 5

Onion

glucose

0.075 ± 0.010

101 ± 1

Oregano

water

0.066 ± 0.020

96 ± 2

Oregano

glucose

0.083 ± 0.030

96 ± 3

Red sweet potato

water

0.067 ± 0.020

95 ± 7

Red sweet potato

glucose

0.054 ± 0.020

90 ± 5
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Table 4: Food samples re-tested in RAW 264.7 macrophages
Food Sample

IC50 for NO production

IC50 for TNF-α

(mg/ml)

production (mg/ml)

Onion

0.13 ± 0.02

0.30 ± 0.01

> 2.5

Oregano

0.13 ± 0.01

0.73 ± 0.06

> 2.5

Oyster mushroom

0.07 ± 0.01

0.23 ± 0.02

> 2.5

Red sweet potato

1.54 ± 0.10

0.51 ± 0.03

> 2.5

Lime zest (glucose)

0.41 ± 0.05

1.02 ± 0.11

> 2.5

Honey brown mushroom

0.81 ± 0.03

1.0 3± 0.14

> 2.5

Button mushroom

0.73 ± 0.01

0.39 ± 0.04

> 2.5

Cinnamon

0.10 ± 0.01

0.45 ± 0.01

> 2.5

Cloves

0.12 ± 0.01

2.12 ± 0.02

> 2.5

English breakfast tea leaves

0.40 ± 0.01

0.30 ± 0.02

> 2.5

0.25 ± 0.09

0.7 ± 0.07

1.36 ± 0.21

(0.69 ± 0.26 mM)

(1.95 ± 0.21 mM)

(3.81 ± 0.59 mM)

0.79 ± 0.08

0.42 ± 0.16

0.34 ± 0.09

(3.83 ± 0.43 mM)

(1.19 ± 0.16mM)

(1.63 ± 0.44 mM)

LC50 (mg/ml)

Anti-inflammatory drug
Prednisone

Ibuprofen

3.2 Secondary screen using a second cell line (RAW 264.7 macrophages) and nitric oxide plus TNF-α as
pro-inflammatory readouts

The 10 most active samples (defined as having an IC50 value of < 0.5 mg/ml or 0.1 mg/ml, respectively) with
demonstrated anti-inflammatory properties from the primary screen were retested in a second cell line with an
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additional pro-inflammatory readout, TNF-α. Since the previous experiment did not show any striking
difference between the original and glucose-modified preparations, no glucose-modified samples were used in
the second screen, except for lime zest, where the availability of the unmodified sample was limited.

These 10 active samples (English breakfast tea leaves, onion, oregano, oyster mushroom, red sweet potato, lime
zest, honey brown mushroom, button mushroom, cinnamon and cloves) were tested by measuring their ability
to down-regulate LPS + IFN-γ induced release of NO and, as a second marker of inflammation, TNF-α (Table
4).

Of the 10 products, oyster mushroom and cinnamon, demonstrated the most significant anti-inflammatory
activities (with IC50 values below 0.1 mg/ml), followed by cloves, oregano, onion, English breakfast tea leaves
and lime zest (with IC50 values below 0.5 mg/ml) in terms of suppression of LPS and IFN-γ induced NO
production. In addition, English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom
preparations also suppressed TNF-α release (with IC50 values below 0.5 mg/ml). Oyster mushroom was the most
active anti-inflammatory sample for both NO inhibition and TNF-α inhibition with IC50 values 0.067 mg/ml and
0.23 mg/ml respectively (Table 4).

In addition, two anti-inflammatory drugs, including prednisone and the non-steroidal anti-inflammatory drug
(NSAID) ibuprofen were tested in the same assay systems. Ibuprofen was toxic to cells at concentrations of 1.63
± 0.44 mM, and NO and TNF-α production were down-regulated at the same concentrations (Table 4).
Prednisone inhibited LPS + IFN-γ induced NO and TNF-α production with IC50 values of 0.25 ± 0.09 mg/ml
(0.69 ± 0.26 mM) and 0.7 ± 0.07 mg/ml (1.95 ± 0.21 mM), respectively (Table 4).

4.

DISCUSSION

The activation of macrophages and microglia leads to secretion of inflammatory molecules such as the proinflammatory cytokine TNF-α and the free radical NO, which play an important role in inflammation and
nitroxidative stress in many age-related diseases, including Alzheimer’s disease (AD) [14]. In the assay systems
used here, the bacterial surface molecule lipopolysaccharide and the cytokine IFN-γ were used to activate
microglia, and NO and TNF-α release were used as readouts [15].
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As control substances, the synthetic corticosteroid prednisone and the non-steroidal anti-inflammatory drug
(NSAID) ibuprofen were also tested in the same assay systems. As expected, ibuprofen as a selective COX-1
and 2 inhibitor did not specifically inhibit LPS and IFN-γ induced NO and TNF-γ production. Interestingly,
prednisone was quite a weak inhibitor of LPS + IFN-γ induced NO and TNF-α production, since in many other
inflammatory paradigms corticosteroids are effective at low micromolar, and in some instances at nanomolar
concentrations [13]. However, it appears that macrophages treated with a combination of LPS and IFN-γ
(compared to LPS alone) are insensitive to anti-inflammatory corticosteroids such as dexamethasone [14, 15],
which is consistent with our observations.
Among the food samples, one hundred and fifteen distinct plants and mushroom preparations were screened for
anti-inflammatory properties by employing in vitro cell-based bio-assays. The extracts of several plants
including onion, oregano, red sweet potato, lime zest, cinnamon and cloves exhibited the strongest capacity to
suppress NO and TNF-α. Interestingly, oyster mushroom, honey brown mushroom and button mushroom
showed also significant anti-inflammatory potential.
Interestingly, a differential effect of MRP modification on the activity of the food preparations was observed,
depending on the sample. Since high molecular MRPs (also termed advanced glycation endproducts, AGEs) are
known to increase inflammation [16, 17], and low molecular MRPs (MW < 1 kDa) have been shown to possess
anti-inflammatory potential [18], it might be the balance between these species which shift the IC50 value up or
down depending on the composition of the sample.
Some of our data are in accordance with published studies on anti-inflammatory properties of the foods
identified as potent in this study. For example, onions have been shown to exhibit anti-inflammatory properties,
e.g. downregulation of adipokine expression in the visceral adipose tissue of rats or attenuation of vascular
inflammation and oxidative stress in fructose-fed rats [19, 20]. Among the polyphenols in onions, quercetin was
suggested to be the responsible anti-inflammatory ingredient, as evidenced by the downregulation of COX2
transcription in human lymphocytes [21]. Furthermore, the anti-inflammatory activity of the onion has been
studied also in relation to the presence of thiosulfinates and cepaenes [22, 23].
Anti-inflammatory properties of cinnamon has been demonstrated for Cinnamomum osmophloem kaneh [24,
25], but less is known about the ‘true’ cinnamon of India, Cinnamomum zeylanicum. Some authors reported
significant inhibitory effects of inflammatory signalling by the extracts of C. cassia [26]. Sodium benzoate
appears to be one of the active ingredients in cinnamon, since it inhibits LPS-induced expression of inducible
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NO synthase (iNOS), pro-inflammatory cytokines (TNF-α and IL-1β) and surface markers for inflammatory
activation such as CD11b, CD11c, and CD68 in mouse microglia [27].
Clove (Syzygium aromaticum) extracts have been identified as having potent free radical (including superoxide
anion) scavenging properties, and metal chelating activities, which may be due to the presence of flavonoids.
Cloves contain considerable concentrations of eugenol, beta-caryophyllene, quercetin and kaempferol as well as
rhamnetin and kaempferol and their glycosides [28]. Our study is in line with studies showing that eugenol
suppresses NF-κB activation, thereby down-regulating cyclooxygenase-2 expression in lipopolysaccharidestimulated macrophages [29-31].
Red sweet potato (Ipomoea batatas), a species rich in β-carotene and anthocyanins [32], has been demonstrated
to have anti-inflammatory properties for the first time by our study. Lime (Citrus aurantifolia) rich in flavonol
glycosides, especially of kaempferol-type are known for their anti-oxidant properties [33], however our study is
also the first to report on its anti-inflammatory activities.
The anti-inflammatory properties of the various mushroom species were quite surprising, since there are only a
handful studies showing such activity. For example, oyster mushroom concentrate (OMC) was shown to
suppress LPS-induced secretion of TNF-α, IL-6 and IL-12p40 in RAW264.7 macrophages and also suppressed
PGE2 and NO by down-regulation of COX-2 and iNOS expression, respectively. OMC also inhibited LPSdependent DNA binding activity of AP-1 and NF-κB in RAW264.7 cells [34]. Our results correlate with these
observations as oyster mushroom extracts inhibited LPS+IFN-γ induced production of NO. In mushrooms,
water-soluble polysaccharides, especially the β-glucans, are most likely to be the substances responsible for the
anti-inflammatory properties. For example, β-glucans isolated Pleurotus ostreatus were able to potentiate the
anti-inflammatory effects of methotrexate in rat models of experimental arthritis or colitis [35, 36]. A further
potential anti-inflammatory compound in mushrooms could be ergothioneine (ET), a sulfur containing amino
acid that functions as an antioxidant and is present in mushrooms at a concentration of up to 2.0mg/g [37]. In
Acute Respiratory Distress Syndrome (ARDS), ergothioneine given intravenously 1h before or 18 h after
cytokine (IL-1 and IFN-γ) insufflation, decreased lung injury and lung inflammation in cytokine insufflated rats
[38].
In summary, it is suggested that foods containing anti-inflammatory properties might be useful in the prevention
of age-related inflammatory conditions, provided that dose and individual bioavailability lead to therapeutic
concentrations in affected tissues. Bioavailability of plant substances including polyphenols is highly variable,
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and will depend on the nature of the compound [39, 40]. Therefore, validation of the active samples in animal
models should eventually follow. Furthermore, we speculate that these natural sources could lead to the
discovery of potent novel anti-inflammatory compounds.
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